Literature DB >> 27611877

Pathologically dissimilar acute stent thromboses in a metal allergic patient.

Takao Konishi1, Daisuke Hotta, Naohiro Funayama, Tadashi Yamamoto, Hiroshi Nishihara, Shinya Tanaka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27611877      PMCID: PMC5287428          DOI: 10.1097/MCA.0000000000000432

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


× No keyword cloud information.
A 66-year-old man was hospitalized with an acute infero-lateral myocardial infarction. A stent thrombosis (ST) developed immediately after implantation of a stent in the distal right coronary artery (Fig. 1a–c). After multiple angioplasty balloon dilatations and insertion of an intra-aortic balloon pump, the formation of thrombi finally ended. The next day, the patient developed recurrent chest pain and an emergent coronary angiography indicated the presence of another acute ST (Fig. 1d–f). Although the patient had no history of metal allergy, a skin patch test elicited a positive response to nickel, cobalt, and chromium, metals included in the composition of the implanted stent. Histopathological examination of thrombi aspirated on the first day showed that they were composed of atherosclerotic plaque with foam cells (Fig. 2a), whereas the thrombi aspirated on the second day contained large numbers of eosinophils with fibrin and erythrocytes on direct fast scarlet staining (Fig. 2b and c). These observations suggested that the first ST was caused by atherosclerotic plaque and thrombus protrusion 1, whereas the second was because of metal allergy. After administration of prednisolone, 10 mg daily, no further ST has been observed. As hypersensitivity to drug-eluting stent components has been reported 2, an allergy to the device should be included in the differential diagnosis of recurrent acute ST.
Fig. 1

Acute stent thromboses. (a) Coronary angiography (CAG) showing the first acute stent thrombosis (ST) after stent implantation. (b, c) The intravascular ultrasound (IVUS) confirmed homogeneous fibrous thrombus (arrow), and multiple white and red thrombi were aspirated (arrows). (d) CAG showing the second ST. (e, f) The IVUS showed heterogeneous thrombus (arrow) and several red thrombi were aspirated (arrows).

Fig. 2

Histopathological examination of aspirated thrombi. (a) The thrombi aspirated on the first day were composed of fibrin and atherosclerotic plaque with foam cells. (b, c) The thrombi aspirated on the second day contained large numbers of eosinophils on direct fast scarlet staining.

Acute stent thromboses. (a) Coronary angiography (CAG) showing the first acute stent thrombosis (ST) after stent implantation. (b, c) The intravascular ultrasound (IVUS) confirmed homogeneous fibrous thrombus (arrow), and multiple white and red thrombi were aspirated (arrows). (d) CAG showing the second ST. (e, f) The IVUS showed heterogeneous thrombus (arrow) and several red thrombi were aspirated (arrows). Histopathological examination of aspirated thrombi. (a) The thrombi aspirated on the first day were composed of fibrin and atherosclerotic plaque with foam cells. (b, c) The thrombi aspirated on the second day contained large numbers of eosinophils on direct fast scarlet staining.
  2 in total

1.  In-stent protrusion after implantation of a drug-eluting stent in a honeycomb-like coronary artery structure: complete resolution over 6 months and the role of optical coherence tomography imaging in the diagnosis and follow-up.

Authors:  Kohei Koyama; Kihei Yoneyama; Takanobu Mitarai; Shingo Kuwata; Yuki Ishibashi; Ken Kongoji; Yoshihiro J Akashi
Journal:  JACC Cardiovasc Interv       Date:  2014-04-16       Impact factor: 11.195

Review 2.  Drug-eluting stent thrombosis: the Kounis hypersensitivity-associated acute coronary syndrome revisited.

Authors:  Jack P Chen; Dongming Hou; Lakshmana Pendyala; John A Goudevenos; Nicholas G Kounis
Journal:  JACC Cardiovasc Interv       Date:  2009-07       Impact factor: 11.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.